Tabacon, Ell Jay C.

HRN: 29/27-86  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2026
CEFUROXIME 750MG (VIAL)
07/09/2026
07/16/2026
IV
750mg
Q8h
Multiple Abrasions Sec To RCI
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines